Capital Advisors Inc’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$926K Buy
10,098
+90
+0.9% +$7.88K 0.01% 173
2026
Q1
$853K Buy
10,008
+413
+4% +$36.8K 0.01% 175
2025
Q4
$758K Buy
9,595
+129
+1% +$10.1K 0.01% 176
2025
Q3
$757K Sell
9,466
-29
-0.3% -$2.47K 0.01% 171
2025
Q2
$863K Buy
9,495
+24
+0.3% +$2.19K 0.02% 158
2025
Q1
$887K Buy
9,471
+19
+0.2% +$1.7K 0.02% 148
2024
Q4
$859K Hold
9,452
0.02% 149
2024
Q3
$981K Hold
9,452
0.02% 147
2024
Q2
$917K Hold
9,452
0.02% 153
2024
Q1
$851K Hold
9,452
0.02% 154
2023
Q4
$753K Buy
9,452
+629
+7% +$47.3K 0.02% 175
2023
Q3
$627K Sell
8,823
-1,018
-10% -$76.1K 0.02% 160
2023
Q2
$758K Buy
9,841
+1,189
+14% +$92K 0.02% 153
2023
Q1
$650K Sell
8,652
-36
-0.4% -$2.68K 0.02% 159
2022
Q4
$685K Sell
8,688
-31
-0.4% -$2.32K 0.02% 161
2022
Q3
$622K Buy
8,719
+467
+6% +$36.6K 0.02% 155
2022
Q2
$661K Hold
8,252
0.02% 157
2022
Q1
$626K Sell
8,252
-176
-2% -$13.9K 0.02% 157
2021
Q4
$719K Buy
8,428
+109
+1% +$8.51K 0.02% 145
2021
Q3
$629K Sell
8,319
-3
-0% -$238 0.02% 148
2021
Q2
$677K Sell
8,322
-16
-0.2% -$1.31K 0.02% 145
2021
Q1
$657K Sell
8,338
-91
-1% -$7.13K 0.02% 139
2020
Q4
$721K Buy
8,429
+1,443
+21% +$119K 0.03% 120
2020
Q3
$539K Buy
6,986
+1,896
+37% +$145K 0.02% 125
2020
Q2
$386K Sell
5,090
-68
-1% -$4.83K 0.02% 137
2020
Q1
$342K Sell
5,158
-21
-0.4% -$1.48K 0.02% 126
2019
Q4
$357K Buy
5,179
+21
+0.4% +$1.43K 0.02% 145
2019
Q3
$370K Hold
5,158
0.02% 143
2019
Q2
$370K Buy
+5,158
New +$366K 0.02% 143
2019
Q1
Sell
-6,067
Closed -$361K 138
2018
Q4
$361K Sell
6,067
-102,860
-94% -$6.44M 0.02% 144
2018
Q3
$7.29M Sell
108,927
-695
-0.6% -$46.3K 0.43% 73
2018
Q2
$7.11M Buy
109,622
+1,237
+1% +$80.9K 0.43% 75
2018
Q1
$7.77M Buy
108,385
+102,337
+1,692% +$7.36M 0.47% 73
2017
Q4
$456K Hold
6,048
0.03% 147
2017
Q3
$441K Buy
+6,048
New +$436K 0.03% 142

Other funds holding CL

Capital Advisors Inc's CL Position: Q2 2026 in Review

Capital Advisors Inc increased its Colgate-Palmolive (CL) stake by 0.9% in Q2 2026, buying an estimated $7.88K and bringing the position to 10,098 shares worth $926K. The position accounts for 0.01% of the portfolio, ranked #173.

Capital Advisors Inc first reported a position in CL in Q3 2017 and has held it in 35 quarters since. The position peaked at $7.77M in Q1 2018. 610 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Capital Advisors Inc held 10,098 shares of Colgate-Palmolive worth $926K as of Q2 2026.
  • Capital Advisors Inc bought 90 Colgate-Palmolive shares in Q2 2026, an estimated $7.88K.
  • Colgate-Palmolive made up 0.01% of Capital Advisors Inc's portfolio in Q2 2026, its #173 holding.
  • Capital Advisors Inc first reported a position in Colgate-Palmolive in Q3 2017 and has held it in 35 quarters since.
  • Capital Advisors Inc's Colgate-Palmolive position peaked at $7.77M in Q1 2018.
  • 610 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Capital Advisors Inc's 13F filing for Q2 2026, filed 23 Jul 2026.